Home » Newsletters » BioWorld

BioWorld

May 10, 1994

View Archived Issues

JAPANESE CLINICIANS INDICT INTERFERON IN HEARING LOSS

ZYNAXIS, TRIPLEX IN RESEARCH, LICENSING AGREEMENT

SYSTEMIX, SANDOZ END SCGF COLLABORATION

FDA APPROVES BOEHRINGER'S CARDIAC ASSAY

APPOINTMENTS AND ADVANCEMENTS

GEN-PROBE FORMS DIVISION FOR OLIGONUCLEOTIDE THERAPEUTICS

CORTECH CONTRACTS FOR MANUFACTURE OF BRADYCOR

OTHER NEWS TO NOTE

PROCYTE ENROLLS PLANTAR ULCER PHASE III PATIENTS

INTERNEURON DEPLORES PANNING OF ITS ANTI-OBESITY DRUG

SONUS COMPLETES PHASE I IMAGING TRIAL

CAMBRIDGE BIOTECH'S CEO LEAVES FOLLOWING INVESTIGATION

ATS IN CARTILAGE STUDY JOINT VENTURE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...